Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab

Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab

Background: Omalizumab, a monoclonal anti-IgE antibody, is currently indicated for the treatment of moderate-to-severe allergic asthma. To measure active IgE levels in sera from patients treated with omalizumab, the IgE subfraction in complex with omalizumab should be eliminated from total IgE, and...

Full description

Bibliographic Details
Main Authors: Reiko Ito, Yasuhiro Gon, Satoshi Nunomura, Ryo Atsuta, Norihiro Harada, Tomohiro Hattori, Shuichiro Maruoka, Yoshimichi Okayama, Chisei Ra, Shu Hashimoto
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Allergology International
Subjects:
asthma
Fc epsilon RI alpha
IgE binding
immunoglobulin E (IgE)
omalizumab
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015300824

Internet

http://www.sciencedirect.com/science/article/pii/S1323893015300824

Similar Items